サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1678720

ピペラジンの世界市場：市場規模・シェア・動向分析 (原料別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)

Piperazine Market Size, Share & Trend Analysis Report, By Source (Natural, Synthetic), By End-use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics), By Region (North America, Europe, APAC), And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 80 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ピペラジンの世界市場：市場規模・シェア・動向分析 (原料別・最終用途別・地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年02月18日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ピペラジン市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のピペラジンの市場規模は2030年までに40億2,400万米ドルに達すると予測され、2025年から2030年までのCAGRは4.1%で成長すると予測されています。

これは、医薬品（抗寄生虫薬など）、農薬（除草剤、殺虫剤）、様々な化学プロセスで幅広く使用されていることに起因しています。

合成ピペラジンの需要が増加しているのは、抗寄生虫薬や一部の抗精神病薬など、様々な医薬品の製造において重要な役割を担っているためです。また、除草剤や殺虫剤のような農薬を製造する際の重要な中間体としての使用も、農業ニーズの増加を背景に、市場の成長を後押ししています。さらに、合成ピペラジンの用途は多様な化学産業に広がっており、ポリマー、樹脂、その他の材料の製造に使用されています。このような多方面にわたる汎用性が、健康への懸念や農業需要の増加と相まって、合成ピペラジン産業の拡大を後押ししています。

農薬業界は、様々な作物保護化学物質の合成に不可欠な役割を果たすため、ピペラジンに大きく依存しています。重要な構成要素として、ピペラジンは雑草を駆除する除草剤、昆虫と闘う殺虫剤、菌類による病気を防ぐ殺菌剤の効果に貢献しています。世界人口の増加と、食糧需要を満たすための作物収量の増加の必要性により、これらの農薬の広範な使用が必要とされています。そのため、これらの農薬の生産に不可欠な原料としてピペラジンの需要が高まっています。

北米におけるピペラジンの需要は、様々な要因が重なって増加傾向にあります。この地域の堅調な製薬セクターは、抗寄生虫薬を含む様々な医薬品の合成にピペラジンを多用しており、その需要に大きく貢献しています。同時に、盛んな農業部門は、作物を保護し、食糧安全保障を確保するために、除草剤や殺虫剤のようなピペラジン由来の農薬に依存しており、その消費をさらに促進しています。

ピペラジン業界の有力企業には、Evonik Industries、Solvay S.A.、Dow、ExxonMobil Corporation、BASF SE、Albemarle Corporation、Shell、Huntsman Corporationなどがあります。

ピペラジン市場レポートハイライト

  • 天然セグメントは予測期間中最も速いCAGR 4.2%で成長する見込みです。天然ピペラジンの需要は、様々な用途でバイオベースかつ持続可能な製品に対する消費者の嗜好の高まりにより拡大しています。
  • 最終用途に基づくと、製薬分野は予測期間中最も速いCAGR 4.6%で成長すると予想されます。製薬分野におけるピペラジンの需要は、抗寄生虫薬、抗ヒスタミン薬、抗精神病薬など、様々な医薬品の合成に重要な役割を果たすことから伸びています。寄生虫感染症や精神疾患の有病率の増加が、この需要をさらに促進しています。
  • 北米は予測期間中、CAGR 4.4%と最速の成長が見込まれています。この成長は、医薬品合成や農薬生産に不可欠なこの地域の強力な医薬・農薬セクターに起因します。さらに、化学産業の成長と健康意識の高まりが需要にさらに貢献しています。
  • 2023年1月、BASF SEはピペラジンやその他の医薬品中間体の中国メーカーであるPharmacy Laboratories社を3,000万米ドルで買収しました。この買収により、BASFは中国市場でのプレゼンスを拡大し、ピペラジン分野の製品ポートフォリオを充実させました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 市場の変動要因・傾向・範囲

  • 世界のピペラジン市場の見通し
  • バリューチェーン分析
    • 原材料の見通し
    • 製造/調達先の見通し
    • 販売チャネル分析
  • 価格動向分析
    • 価格に影響を与える要因
  • 規制の枠組み
    • 標準とコンプライアンス
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
    • 市場機会の分析
    • 市場の課題の分析
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • バイヤーの交渉力
    • 代替の脅威
    • 新規参入企業の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的要因
    • 経済的要因
    • 社会的要因
    • 技術的要因
    • 環境的要因
    • 法的要因

第4章 ピペラジン市場：原料別の推定・動向分析

  • ピペラジン市場：変動分析、原料別 (2024年・2030年)
  • 天然
  • 合成

第5章 ピペラジン市場： 最終用途の推定・動向分析

  • ピペラジン市場：変動分析、最終用途別 (2024年・2030年)
  • 製薬
  • 農薬
  • パーソナルケア・化粧品
  • その他の用途

第6章 ピペラジン市場：地域別の推定・動向分析

  • 地域別分析 (2024年・2030年)
  • 北米
    • 原料別 (2018～2030年)
    • 最終用途別 (2018～2030年)
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 原料別 (2018～2030年)
    • 最終用途別 (2018～2030年)
    • ドイツ
    • 英国
    • フランス
  • アジア太平洋
    • 原料別 (2018～2030年)
    • 最終用途別 (2018～2030年)
    • 中国
    • インド
    • 日本
  • ラテンアメリカ
    • 原料別 (2018～2030年)
    • 最終用途別 (2018～2030年)
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 原料別 (2018～2030年)
    • 最終用途別 (2018～2030年)
    • サウジアラビア
    • 南アフリカ

第7章 競合情勢

  • 最近の動向：主要市場参入企業
  • 企業分類
  • 企業ヒートマップ分析
  • 企業市場ポジショニング分析（2024年）
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • BASF SE
    • Evonik Industries
    • Dow
    • Solvay SA
    • ExxonMobil Corporation
    • Albemarle Corporation
    • Shell
    • Huntsman Corporation
図表

List of Tables

  • Table 1 Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 2 Natural Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 3 Synthetic Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 4 Piperazine market estimates & forecasts, in pharmaceutical, 2018 - 2030 (USD Million)
  • Table 5 Piperazine market estimates & forecasts, by agrochemical, 2018 - 2030 (USD Million)
  • Table 6 Piperazine market estimates & forecasts, by personal care & cosmetics, 2018 - 2030 (USD Million)
  • Table 7 Piperazine market estimates & forecasts, by other end uses, 2018 - 2030 (USD Million)
  • Table 8 Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 9 Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 10 Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 11 North America polyurethane Coatings market estimates & forecast, 2018 - 2030 (USD Million)
  • Table 12 North America Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 13 North America Piperazine market estimates & forecasts by application, 2018 - 2030 (USD Million)
  • Table 14 U.S. Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 15 U.S. Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 16 U.S. Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 17 Canada Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 18 Canada Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 19 Canada Piperazine market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 20 Canada Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 22 Mexico Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 23 Mexico Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 24 Europe Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 25 Europe Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 26 Europe Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 28 Germany Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 29 Germany Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 30 Uk Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 31 Uk Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 32 Uk Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 33 France Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 34 France Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 35 France Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 36 Asia pacific Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 37 Asia pacific Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 38 Asia pacific Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 39 China Piperazine market estimates & forecast, 2018 - 2030 (USD Million)
  • Table 40 China Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 41 China Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 42 India Piperazine market estimates & forecast, 2018 - 2030 (USD Million)
  • Table 43 India Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 44 India Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 45 Japan Piperazine market estimates & forecast, 2018 - 2030 (USD Million)
  • Table 46 Japan Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 47 Japan Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 48 South Korea Piperazine market estimates & forecast, 2018 - 2030 (USD Million)
  • Table 49 South Korea Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 50 South Korea Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 51 Latin America Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 52 Latin America Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 53 Latin America Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 54 Brazil Piperazine market estimates & forecast, 2018 - 2030 (USD Million)
  • Table 55 Brazil Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 56 Brazil Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 57 Argentina Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 58 Argentina Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 59 Argentina Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 60 Middle East & Africa Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 61 Middle East & Africa Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 62 Middle East & Africa Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 64 Saudi Arabia Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 65 Saudi Arabia Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 66 South Africa Piperazine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 67 South Africa Piperazine market estimates & forecasts by source, 2018 - 2030 (USD Million)
  • Table 68 South Africa Piperazine market estimates & forecasts by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market snapshot
  • Fig. 7 Segmental outlook -End Use & Source
  • Fig. 8 Competitive Outlook
  • Fig. 9 Piperazine market outlook, 2018-2030 (USD Million)
  • Fig. 10 Value chain analysis
  • Fig. 11 Market dynamics
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTEL Analysis
  • Fig. 14 Piperazine market, by source: Key takeaways
  • Fig. 15 Piperazine market, by source: Market share, 2024 & 2030
  • Fig. 16 Piperazine market, by end use: Key takeaways
  • Fig. 17 Piperazine market, by end use: Market share, 2024 & 2030
  • Fig. 18 Piperazine market: Regional analysis, 2024
  • Fig. 19 Piperazine market, by region: Key takeaways
目次
Product Code: GVR-4-68040-523-9

Piperazine Market Growth & Trends:

The global piperazine market size is anticipated to reach USD 4,024 million by 2030 and is projected to grow at a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is attributable to its wide use in pharmaceuticals (antiparasitic drugs, etc.), agrochemicals (herbicides, pesticides), and various chemical processes.

The demand for synthetic piperazine is rising due to its crucial role in manufacturing various pharmaceuticals, including antiparasitic drugs and some antipsychotics. Its use as a key intermediate in producing agrochemicals like herbicides and pesticides also fuels market growth, driven by increasing agricultural needs. Furthermore, synthetic piperazine's applications extend to diverse chemical industries, where it's used in making polymers, resins, and other materials. This versatility across multiple sectors, coupled with increasing health concerns and agricultural demands, is driving the expansion of the synthetic piperazine industry.

The agrochemicals industry relies heavily on piperazine due to its essential role in synthesizing various crop protection chemicals. As a key building block, piperazine contributes to the effectiveness of herbicides that control weeds, pesticides that combat insects, and fungicides that prevent fungal diseases. The increasing global population, coupled with the need for higher crop yields to meet food demands, necessitates the widespread use of these agrochemicals. This, in turn, fuels the demand for piperazine as a vital raw material in their production.

The demand for piperazine in North America is on the rise, fueled by a confluence of factors. The region's robust pharmaceutical sector heavily relies on piperazine for synthesizing various medications, including antiparasitic drugs, contributing significantly to its demand. Simultaneously, the thriving agricultural sector depends on piperazine-derived agrochemicals like herbicides and pesticides to safeguard crops and ensure food security, further driving its consumption.

Some of the prominent players in the Piperazine industry include Evonik Industries, Solvay S.A., Dow, ExxonMobil Corporation, BASF SE, Albemarle Corporation, Shell, and Huntsman Corporation.

Piperazine Market Report Highlights:

  • The natural segment is expected to grow at the fastest CAGR of 4.2% during the forecast period. The demand for natural piperazine is growing due to increasing consumer preference for bio-based and sustainable products in various applications.
  • Based on end use, the pharmaceutical segment is expected to grow at the fastest CAGR of 4.6% during the forecast period. Piperazine demand in the pharmaceutical sector is growing due to its crucial role in synthesizing various drugs, including antiparasitic medications, antihistamines, and antipsychotics. The increasing prevalence of parasitic infections and mental health disorders further fuels this demand.
  • North America is expected to grow at the fastest CAGR of 4.4% during the forecast period. This growth is attributed to the region's strong pharmaceutical and agrochemical sectors, where it's crucial for drug synthesis and pesticide production. In addition, a growing chemical industry and increasing health awareness further contribute to the demand.
  • In January 2023, BASF SE acquired Pharmacy Laboratories, a Chinese manufacturer of piperazine and other pharmaceutical intermediates, for USD 30 million. The acquisition helped BASF to expand its presence in the Chinese market and increase its product portfolio in the piperazine segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Information Analysis
    • 1.3.2. Market Formulation & Data Visualization
    • 1.3.3. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Global Piperazine Market Outlook
  • 3.2. Value Chain Analysis
    • 3.2.1. Raw Material Outlook
    • 3.2.2. Manufacturing/Source Outlook
    • 3.2.3. Sales Channel Analysis
  • 3.3. Price Trend Analysis
    • 3.3.1. Factors Influencing Prices
  • 3.4. Regulatory Framework
    • 3.4.1. Standards & Compliances
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
    • 3.5.2. Market Restraint Analysis
    • 3.5.3. Market Challenges Analysis
    • 3.5.4. Market Opportunity Analysis
  • 3.6. Porter's Five Forces Analysis
    • 3.6.1. Bargaining Power of Suppliers
    • 3.6.2. Bargaining Power of Buyers
    • 3.6.3. Threat of Substitution
    • 3.6.4. Threat of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTLE Analysis
    • 3.7.1. Political
    • 3.7.2. Economic
    • 3.7.3. Social Landscape
    • 3.7.4. Source
    • 3.7.5. Environmental
    • 3.7.6. Legal

Chapter 4. Piperazine Market: Source Estimates & Trend Analysis

  • 4.1. Piperazine Market: Source Movement Analysis, 2024 & 2030
  • 4.2. Natural
    • 4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3. Synthetic
    • 4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Piperazine Market: End Use Estimates & Trend Analysis

  • 5.1. Piperazine Market: End Use Movement Analysis, 2024 & 2030
  • 5.2. Pharmaceutical
    • 5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3. Agrochemicals
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Personal Care & Cosmetics
    • 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Other End Uses
    • 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Piperazine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Analysis, 2024 & 2030
  • 6.2. North America
    • 6.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
    • 6.2.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.2.4. U.S.
      • 6.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.4.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.2.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.2.5. Canada
      • 6.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.5.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.2.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.2.6. Mexico
      • 6.2.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.6.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.2.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
    • 6.3.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.3.4. Germany
      • 6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.4.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.3.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.3.5. UK
      • 6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.5.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.3.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.3.6. France
      • 6.3.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.6.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.3.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
    • 6.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.4.4. China
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.4.4.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.4.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.4.5. India
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.4.5.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.4.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.4.6. Japan
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.4.6.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.4.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
    • 6.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.5.4. Brazil
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.5.4.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.5.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.5.5. Argentina
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.5.5.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.5.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
    • 6.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.6.4. Saudi Arabia
      • 6.6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.6.4.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.6.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.6.5. South Africa
      • 6.6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.6.5.2. Market estimates and forecasts, by source, 2018 - 2030 (USD Million)
      • 6.6.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Market Positioning Analysis, 2024
  • 7.5. Strategy Mapping
  • 7.6. Company Profiles/Listing
    • 7.6.1. BASF SE
      • 7.6.1.1. Company Overview
      • 7.6.1.2. Financial Performance
      • 7.6.1.3. Source Benchmarking
    • 7.6.2. Evonik Industries
      • 7.6.2.1. Company Overview
      • 7.6.2.2. Financial Performance
      • 7.6.2.3. Source Benchmarking
    • 7.6.3. Dow
      • 7.6.3.1. Company Overview
      • 7.6.3.2. Financial Performance
      • 7.6.3.3. Source Benchmarking
    • 7.6.4. Solvay S.A.
      • 7.6.4.1. Company Overview
      • 7.6.4.2. Financial Performance
      • 7.6.4.3. Source Benchmarking
    • 7.6.5. ExxonMobil Corporation
      • 7.6.5.1. Company Overview
      • 7.6.5.2. Financial Performance
      • 7.6.5.3. Source Benchmarking
    • 7.6.6. Albemarle Corporation
      • 7.6.6.1. Company Overview
      • 7.6.6.2. Financial Performance
      • 7.6.6.3. Source Benchmarking
    • 7.6.7. Shell
      • 7.6.7.1. Company Overview
      • 7.6.7.2. Financial Performance
      • 7.6.7.3. Source Benchmarking
    • 7.6.8. Huntsman Corporation
      • 7.6.8.1. Company Overview
      • 7.6.8.2. Financial Performance
      • 7.6.8.3. Source Benchmarking